![]() |
|
|
Vol. 12, Issue 1, 73-83, January 2001



and
*Department of Cell and Molecular Biology, Umeå University, S-901
87 Umeå, Sweden; and
Department of Biological
Sciences, Lehigh University, Bethlehem, Pennsylvania 18015
| |
ABSTRACT |
|---|
|
|
|---|
Oncoprotein18/stathmin (Op18) is a microtubule (MT) destabilizing protein that is inactivated during mitosis by phosphorylation at four Ser-residues. Op18 has at least two functions; the N-terminal region is required for catastrophe-promotion (i.e., transition from elongation to shortening), while the C-terminal region is required to inhibit MT-polymerization rate in vitro. We show here that a "pseudophosphorylation" derivative of Op18 (i.e., four Ser- to Glu-substitutions at phosphorylation sites) exhibits a selective loss of catastrophe-promoting activity. This is contrasted to authentic phosphorylation, which efficiently attenuates all activities except tubulin binding. In intact cells, overexpression of pseudophosphorylated Op18, which is not phosphorylated by endogenous kinases, is shown to destabilize interphase MTs but to leave spindle formation untouched. To test if the mitotic spindle is sensitive only to the catastrophe-promoting activity of Op18 and resistant to C-terminally associated activities, N- and C-terminal truncations with defined activity-profiles were employed. The cell-cycle phenotypes of nonphosphorylatable mutants (i.e., four Ser- to Ala-substitutions) of these truncation derivatives demonstrated that catastrophe promotion is required for interference with the mitotic spindle, while the C-terminally associated activities are sufficient to destabilize interphase MTs. These results demonstrate that specific Op18 derivatives with defined activity-profiles can be used as probes to distinguish interphase and mitotic MTs.
| |
INTRODUCTION |
|---|
|
|
|---|
Microtubules (MTs) are polar polymers of
/
-tubulin
heterodimers, which continuously switch between polymerization and
depolymerization, a process termed "dynamic instability" (Desai and
Mitchison, 1997
). Regulation of dynamics is achieved by two broad
classes of proteins, namely MT stabilizers and destabilizers. The
former class is exemplified by microtubule-associated proteins (MAPs),
which are, in general, thought to stabilize MTs by binding along the
polymer (Cassimeris, 1999
). Oncoprotein18/stathmin (Op18) and
XKCM1 are two recently identified destabilizers of MTs, both of which
bind free tubulin dimers. These two MT-destabilizing proteins have been
shown to stimulate transitions from elongation to shortening of MTs and are referred to as catastrophe-promoters (Walczak, 2000
).
Op18 is a 149-amino acid protein that was initially studied due to
up-regulated expression in various types of malignancies and to a
complex phosphorylation pattern that changes in response to multiple
signals and through the cell cycle (Lawler, 1998
). Phosphorylation,
which switches off the MT-destabilizing function of Op18, is mediated
by both cell cycle and cell surface receptor-regulated kinase systems
on four Ser-residues (Deacon et al., 1999
). The phenotype of
Op18 mutants that are deficient in kinase target sites in human
cell lines reveal that phosphorylation-inactivation is essential to
allow microtubules to segregate condensed chromosomes (Marklund
et al., 1994
, 1996
; Larsson et al., 1995
).
Functional inactivation by extensive mitotic phosphorylation argues
against an active role of Op18 during mitosis (Larsson et
al., 1997
). Rather, signal-dependent control of Op18 activities
via phosphorylation by several receptor regulated kinase systems
suggests that the primary role for Op18 is to regulate the MT system in
interphase cells (Gradin et al., 1997
, 1998
). The
physiological importance of such a role is indicated by the observation
that ablation of the Op18 protein in interphase newt lung cells results
in a 2.5-fold increase in MT polymer and an associated decrease in
catastrophe frequency (Howell et al., 1999a
).
Op18 is the prototype member of a family of proteins with
microtubule-regulatory function (Ozon et al., 1997
). Three
major models have been proposed for regulation of microtubule dynamics mediated by Op18. The first and simplest of these models infers that
Op18 acts as a pure tubulin-sequestering protein (Curmi et al., 1997
; Jourdain et al., 1997
). The second model
infers that Op18 specifically promotes catastrophes (Belmont and
Mitchison, 1996
). The third model, which is an extension of the second
model, infers that Op18 mediates at least two distinct
activities
namely, catastrophe-promotion, which requires the
N-terminal part of Op18, and a tubulin sequestering-like activity
observed during MT-assembly in vitro, which requires the
C-terminal part of Op18 (Howell et al., 1999b
; Larsson
et al., 1999b
). The evidence for the third model includes
genetic dissection of specific MT-directed activities both in intact
cells and in vitro.
Specific combinations of Op18 phosphorylation on four
Ser-residues attenuate the inhibitory activity of Op18 on taxol-driven MT polymerization in vitro (Larsson et al., 1997
) and the
MT-destabilizing activity of overexpressed Op18 in intact cells (Gradin
et al., 1997
, 1998
). Substitution of Ser/Thr phosphorylation
sites with negatively charged amino acids, such as Glu or Asp, results
in at least a partial mimic of phosphorylation
("pseudophosphorylation"). However, apparently contradictory
results have been reported using pseudophosphorylated mutants that have
variously been shown to be completely inactive or to be
undistinguishable from wild-type Op18 (Curmi et al., 1997
;
Horwitz et al., 1997
; Larsson et al., 1997
; Gavet
et al., 1998
). In these studies, diverse experimental systems in intact cells and in vitro have been employed to assess different activities of Op18. Because Op18 appears to mediate multiple
MT/tubulin directed activities, conflicting results with pseudophosphorylation mutants may reflect selective attenuation of a
specific activity of Op18.
Here we extend our mutant dissection of the molecular mechanisms by which Op18 regulates the MT-system. By analyzing MT/tubulin directed activities of a pseudophosphorylated Op18 derivative and specific N- and C-terminal truncation mutants of Op18, we provide evidence that interphase and mitotic MTs are differentially sensitive to specific activities of Op18.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
DNA constructs, expression and purification of recombinant proteins
Full-length Op18 with all 4 Ser-phosphorylation sites, namely
Ser-16, Ser-25, Ser-38 and Ser-63, exchanged to Ala (Op18-tetraA) or
Glu (Op18-tetraE) have been described (Larsson et al., 1995
, 1999a
). Where indicated (-F), an 8-amino acid C-terminal Flag epitope
was introduced as described (Marklund et al., 1994
).
Flag-tagged truncated Op18 derivatives with deletions of either the
sequence encoding amino acid 100-147 (Op18-
100-147-F) or the
sequence encoding amino acid 4-24 (Op18-
4-24-F) have previously
been described (Howell et al., 1999b
). It should be noted
that Op18-
4-24-F was termed Op18-
5-25-F in its original
description, but these derivatives are identical, as both positions 5 and 25 of Op18 contain Ser-residues. To construct nonphosphorylatable
derivatives of Op18-
100-147-F and Op18-
4-24-F, four Ala
substitutions were introduced by a general strategy, whereby mutations
were introduced into subfragments of the coding region by single or
overlapping polymerase chain reaction (Ho et al., 1989
). The
resulting derivatives were termed Op18-
100-147-tetraA-F, which
carries Ser-16, -25, -38, and -63 to Ala substitutions, and
Op18-
4-24-tetraA-F, which carries Ser-25, -38, and -63 to Ala
substitutions and an additional Ala substitution at the position Ser-3
to exclude phosphorylation of this residue in the amino acid 4-24
truncated protein. For expression of Op18 deletion mutants in human
cell lines, coding regions were cloned, as HindIII to
BamHI fragments, into the corresponding sites of the
Epstein-Barr Virus-based shuttle vector pMEP4 (Marklund
et al., 1994
). Op18 derivatives were expressed and purified
from Escherichia coli using pET-3d expression, as previously
described (Marklund et al., 1994
). The coding sequence of
fragments generated by polymerase chain reaction were confirmed by
nucleotide sequence analysis using ABI PRISM dye terminator cycle
sequencing kit from Perkin Elmer-Cetus (Norwalk, CT).
Quantification of Ectopic Op18 and Analysis of Op18 Phosphoisomers
To analyze Op18 phosphoisomers, we employed a native-PAGE system
that separates Op18 according to the charge differences introduced by
each of the four identified phosphorylations (Marklund et
al., 1993
). Op18 phosphoisomers were detected by probing filters
with affinity-purified anti-Op18 (Brattsand et al., 1993
).
In experiments involving detection of truncated Op18 derivatives, which
all contain a C-terminal Flag epitope, the anti-Flag-M2 antibody
(Sigma, St. Louis, MO) together with the ECL detection system (Amersham
Pharmacia Biotech, Arlington Heights, IL) were used. To determine Op18
expression levels, cell extracts were separated by SDS-PAGE together
with graded amounts of recombinant Op18, as described (Marklund
et al., 1996
).
Transfection of Human K562 Erythroleukemia Cells
The conditions used for transfection studies and the pMEP4
shuttle vector system have previously been described (Marklund et
al., 1994
). Conditional expression of various Op18 derivatives was
achieved by employing the hMTIIa promoter, which can be suppressed by
low concentrations of EDTA (50 µM) and induced by
Cd2+ (Marklund et al., 1994
). Using
pMEP-Op18 derivatives without the Flag-epitope, 12 µg DNA was used
for transfection, and expression was induced with 0.05 µM
Cd2+. To obtain comparable expression of
Flag-epitope tagged full-length and truncated Op18 mutants, 0.5 µM
Cd2+ was used to induce expression, and the
amount of pMEP DNA was adjusted as follows: Op18-tetra-A-F, 6 µg;
Op18-
4-24-tetraA-F, 6 µg; Op18-
100-147-tetraA-F, 12 µg. The
total amount of DNA was adjusted to 12 µg by adding pMEP vector control.
Analysis of MT-Polymerization Status, Flow Cytometric Analysis, and Immunofluorescence
The cellular content of MT polymers was determined essentially
as described (Gradin et al., 1998
). In brief, cells were
resuspended in an MT-stabilizing buffer containing 0.05% saponin, to
extract soluble tubulin, and were subsequently fixed in 4%
paraformaldehyde/0.05% glutaraldehyde. The remaining polymerized
tubulin was stained with anti-
-tubulin (clone B-5-1-2, Sigma) and
fluorescein-conjugated rabbit anti-mouse immunoglobulin. Fluorescence
was quantitated by flow cytometry using a FACS-calibur together with
the Cell Quest software (Becton-Dickinson, Mountain View, CA).
To allow calculation of the percentage of polymerized tubulin in
relation to the total amount of cellular tubulin, polymerization status in vector-control transfected cells was determined by quantitative western blotting (mean of 3 independent determinations: 58, ±12%). Relative fluorescence intensities of extracted cells were normalized in
each experiment, assuming that the level in vector-control cells
corresponded to 58% polymerized tubulin. This procedure faithfully
reproduced the results obtained by quantification of soluble and
particulate tubulin by western-blot analysis (Larsson et
al., 1999b
), but with increased reproducibility. Within the time
limits of the experiments, ectopic Op18 does not alter the cellular
levels of total tubulin in K562 cells. Analysis of DNA content and
quantification of mitotic cells, using the MPM-2 antibody, was
performed by flow cytometric analysis as described (Marklund et
al., 1996
). Immunofluorescence analysis and laser scanning confocal microscopy was performed as described (Marklund et
al., 1996
).
Analysis of Op18-Tubulin Binding and Dissociation
A detailed account of Op18-tubulin equilibrium binding
experiments has previously been reported (Larsson et al.,
1999b
). In brief, C-terminally Flag-tagged Op18 derivatives (2 µM)
and tubulin (0.8-36 µM) were mixed in PEM buffer (80 mM
piperazine-N,N'-bis[2-ethanesulfonic acid], 1 mM EGTA, 4 mM Mg2+, pH 7.5) and were allowed to associate on
ice for ~ 15 min. Op18-F-tubulin mixes (48 µl) were added to
agarose beads (12 µl), coupled with the Flag-epitope specific M2
antibody (Sigma), and incubated for 15 min at 8°C to capture
Op18-F-tubulin complexes. To allow rapid separation of Op18-tubulin
complexes bound to M2-beads, the bead suspension was applied into the
cap of an 1.5 ml Eppendorf tube containing a bottom layer of 0.4 ml of
PEM complemented with 27% sucrose/17% glycerol, pH 6.8, and a top
layer of 0.2 ml of PEM with 17% glycerol, pH 6.8. The samples were
centrifuged (1 min, 21 000 × g) to separate bead-bound
and free material. To allow simultaneous quantification of Op18 and
tubulin in the same sample, tubulin was labeled with
[
-32P]GTP and Op18 was labeled with
[125I]. There are two major benefits with this
strategy. First, the amount of Op18-F (~ 30% of total Op18-F)
present in the fraction of free tubulin after separation of M2 coupled
beads can be compensated for in each data point; second, only
biologically active (i.e. GTP-bound) tubulin was detected in the
fraction of free tubulin. To calculate equilibrium dissociation
constants, data points from equilibrium binding experiments were fitted
either to a hyperbola or to a model assuming two-site positive
cooperativity in binding (Koshland Jr et al., 1966
) as
described (Larsson et al., 1999b
).
Dissociation rates of Op18-tubulin complexes were determined as
described (Larsson et al., 1999b
). In brief, M2-beads coated with Flag-tagged Op18 derivatives were incubated with tubulin (20 µM)
for 15 min at 8°C to attain equilibrium binding. Before centrifugation through a sucrose/glycerol cushion, bead suspensions were diluted 100-fold in PEM (pH 6.8 or pH 7.5) and incubated for 20 to
900 s. Op18-tubulin complexes were quantitated by the dual isotope
labeling strategy described above. Dissociation rates were calculated
assuming one phase exponential decay using GraphPad Prism software (San
Diego, CA).
In Vitro Phosphorylation of Op18
Purified recombinant Op18 was in vitro phosphorylated on Ser-16
and Ser-63 to high stoichiometry with cAMP dependent protein kinase
(New England BioLabs, Inc., Beverly, MA) by incubating 2.8 U
kinase/µg Op18 in 50 mM Tris-HCl, pH 7.5, 10 mM
MgCl2, and 500 µM ATP for 3 h at 30°C.
Reactions were terminated by heating to 75°C for 10 min and
precipitated overnight at
20°C with 6 volumes of MeOH containing
1% sucrose. The precipitate was washed twice with 75% MeOH containing
1% sucrose, dried under vacuum, and resuspended in PEM buffer. To
remove the protein kinase, which remained insoluble after MeOH
precipitation, the final preparation of phosphorylated Op18 was
clarified by centrifugation (15 min, 21,000Xg). As controls,
in vitro phosphorylations were also performed in the absence of ATP.
Analysis of phosphorylated Op18 on native gels showed that more than
90% was phosphorylated on two sites, which have been identified as
Ser-16 and Ser-63 in a previous study (Gradin et al., 1998
).
Assays of Tubulin GTPase Activity
Analysis of tubulin GTPase activity was performed in PEM buffer
containing 5 mM adenyl-5'-yl imidodiphosphate (AMP-PNP; to inhibit
nonspecific ATPase activity), as described (Larsson et al.,
1999b
). In brief, tubulin was incubated with
[
-32P]GTP,
tubulin-[
-32P]GTP complexes were recovered
by centrifugation through a desalting column (P-30 Micro Bio-Spin,
Bio-Rad, Richmond, CA), and single-turnover GTP hydrolysis was followed
at 37°C. Control experiments showed that the Op18 preparations used
neither bind nor hydrolyze [
-32P]GTP.
Nucleotide hydrolysis was quantitated by ascending chromatography as
described (Austin and Dixon, 1992
).
MT Assembly
The assembly of individual MTs seeded from axoneme fragments was
visualized using video-enhanced differential interference contrast
(DIC) microscopy as described (Howell et al., 1999b
). Assembly conditions were such that MTs assembled only from axonemes and
the total amount of tubulin incorporated into MT polymer were insignificant compared with the total tubulin concentration. The buffers used in the present study were PEM buffers adjusted to either
pH 6.8 or pH 7.5.
| |
RESULTS |
|---|
|
|
|---|
Interphase and Mitotic Phenotypes of Pseudophosphorylated Op18
Op18 is phosphorylated to high stoichiometry at mitosis, which
results in its inactivation (Marklund et al., 1996
; Larsson et al., 1997
). Hence, due to mitotic phosphorylation,
ectopic expression of wild-type Op18 (Op18-wt) destabilizes the
interphase array of MTs without interfering with spindle formation
during mitosis. However, the Op18-tetraA, a mutant with all four
Ser-phosphorylation sites substituted with Ala is nonphosphorylatable
and therefore constitutively active, and ectopic expression blocks
formation of the mitotic spindle (Marklund et al., 1996
). A
general assumption is that the effect of Ser-to-Ala substitutions
reflects only lack of phosphorylation of a particular site in intact
cells, and that the Ala substitutions per se have no other effects.
Substitutions of a Ser-phosphorylation site with a negatively charged
Glu residue, on the other hand, is expected to provide at least a
partial mimic of a negatively charged phosphate group. A mutant of Op18
with all four Ser-phosphorylation sites substituted with Glu (termed Op18-tetraE in this study) has been variously reported to be either active or inactive, depending on the in vivo or in vitro assay system
used (Curmi et al., 1997
; Horwitz et al., 1997
;
Gavet et al., 1998
; Larsson et al., 1999a
).
Using a conditional shuttle-vector based expression system, Op18-wt,
Op18-tetraA, and Op18-tetraE were overexpressed in the human K562
leukemia cell line, and Op18 phosphoisomers were analyzed by native
PAGE (Figure 1A). It is evident that
Op18-wt is expressed as a mixture of non-, mono-, di- and traces of
tri- and tetra-phosphorylated proteins. As expected, Op18-tetraA and
Op18-tetraE are nonphosphorylated and migrate as single bands (note
that 4 negatively charged Glu residues of Op18-tetraE alter the
migration and that the faint, slow migrating band at the top is
endogenous Op18). Quantification of expression levels after 6 and
24 h of Cd2+ induced expression showed rapid
and high expression of all three derivatives (Figure 1B). Analysis of
MT polymerization status in transfected cells revealed that all three
Op18 derivatives caused a major collapse of the MT-system. However, the
severity of the disorder caused by Op18-tetraA and Op18-wt is clearly
stronger than the disorder caused by Op18-tetraE. Induced expression of all Op18 derivatives results in depolymerization of MTs within 6 h
of induced expression. Given the division time of K562 of ~ 20 h,
the data at 6 h reflect mainly MT-destabilization during the
interphase of the cell cycle.
|
To determine if ectopic Op18-tetraE allows formation of the mitotic
spindle, the DNA profiles of Op18 transfected cells were analyzed
(Figure 2). As expected from
phosphorylation-inactivation of Op18 during mitosis (Marklund et
al., 1996
), Op18-wt does not alter the cell cycle distribution,
while Op18-tetraA causes an almost complete mitotic block at 24 h,
followed by mitotic slippage and endoreduplication after 72 h of
induced expression. The observed effect after 72 h is due to a
defect in the metaphase checkpoint of K562, which is frequently
observed among malignant cells (Cahill et al., 1999
).
Importantly, Op18-tetraE expression causes essentially no alteration of
the cell cycle profile. This is not due to a general cell cycle arrest,
since Op18-tetraE expressing cells readily accumulate in mitosis in the
presence of the MT-directed drug nocodazole (see insert in Figure 2).
|
Functional Dissection of Op18-tetraE and Phosphorylated Op18
The data above suggest that the pseudophosphorylated Op18-tetraE
derivative lacks a property essential for interference with spindle
formation, while still retaining properties that destabilize the
MT-system during the interphase. This contrasts to authentic phosphorylation, which blocks all detectable MT-destabilizing activity
of Op18 during both interphase and mitosis (Marklund et al.,
1996
; Larsson et al., 1997
; Gradin et al., 1998
).
It was therefore of interest to compare the profiles of
MT/tubulin-directed in vitro activities of Op18-tetraE with Op18-wt
phosphorylated on Ser-16 and Ser-63. Dual phosphorylation on these two
sites had previously been shown to be sufficient to attenuate the
MT-destabilizing activity of Op18 in intact cells (Gradin et
al., 1998
).
Equilibrium binding analysis of Op18-wt, Op18-tetraE, and
phosphorylated Op18 shows that all bind two tubulin heterodimers by a
mechanism involving two-site positive cooperativity (Figure 3A and B, and Table
1). This implies that all derivatives
bind the first tubulin with low affinity, which generates a second high
affinity-binding site and a subsequent formation of a ternary tubulin2-Op18 complex. Glu-substitution results
in a 3- to 4-fold decrease in the tubulin-affinity, which is in
agreement with the 3-fold decrease estimated by plasmon resonance
measurement (Curmi et al., 1997
), and most importantly, the
difference between Op18-tetraE and phosphorylated Op18 is only
~ 2-fold (see summary of calculated affinities, Table 1). To
characterize modulation of the stability of Op18-tubulin interactions
by phosphorylation and Glu-substitutions, we determined the
dissociation rates. The data in Table 2
shows that Op18-tubulin complexes rapidly dissociate upon dilution, and
as expected from the reported pH regulation of binding affinity (Curmi
et al., 1997
), dissociation is more rapid at the higher pH
(compare data obtained at pH 6.8 and pH 7.5). As anticipated from
decreased binding affinities, both phosphorylation and
Glu-substitutions result in increased dissociation rates. It is notable
that the difference in dissociation rates between Op18-tetraE and
phosphorylated Op18 is modest and that the relative differences in
dissociation rates are very similar at both pH 6.8 and pH 7.5 (see
relative T1/2 values, Table 2).
|
|
|
In contrast to tubulin binding characteristics described above, there is a major difference in the potency with which Op18-tetraE and phosphorylated Op18 stimulate tubulin GTPase activity (Figure 3C). Thus, the Glu-substitutions have no detectable effect, while authentic phosphorylation results in almost complete attenuation of tubulin GTPase stimulatory activity, even at high Op18 concentration. This indicates an important difference between Glu substitution and authentic phosphorylation that cannot be attributed to differences in tubulin binding affinities.
A recent study (Howell et al., 1999b
), which involved in
vitro MT assembly assays, showed that Op18 has a specific plus end directed catastrophe-promoting activity at pH 7.5, while an MT growth
rate inhibitory activity that does not discriminate between plus and
minus ends (i.e., sequestering-like activity) predominates at pH 6.8. It is evident from Figure 4A that
Op18-tetraE shows activity similar to Op18-wt with respect to
inhibition of growth rate at pH 6.8. In agreement with earlier results
(Howell et al., 1999b
), Op18 does not inhibit growth rate at
pH 7.5. Interestingly, however, Glu-substitutions abolish the specific
plus end directed catastrophe-promoting activity of Op18 (Figure 4B).
The corresponding analysis of phosphorylated Op18 reveals attenuation
of both growth rate inhibition at pH 6.8 and catastrophe activity at pH
7.5 (Figure 5).
|
|
In conclusion, both Glu-substitutions and authentic phosphorylation on Ser-16 and Ser-63 attenuate the catastrophe-promoting activity of Op18. However, the Op18-tetraE derivative retains MT growth rate inhibitory activity and efficiently stimulates the intrinsic tubulin GTPase activity. The effect of either phosphorylation or Glu-substitution on tubulin binding is significant; however, it is insufficient to explain differences in the in vitro activity profiles. Hence, it appears that Glu-substitutions result in selective attenuation of the catastrophe-promoting activity of Op18.
Nonphosphorylatable Truncation Mutants Link the Catastrophe-promoting Activity of Op18 to Disruption of the Mitotic Spindle
The apparently selective loss of in vitro catastrophe activity of
Op18-tetraE suggested that disruption of the mitotic spindle by
nonphosphorylatable Op18 derivatives may require the
catastrophe-promoting activity of Op18, while other MT-destabilizing
activities of Op18 are sufficient for a substantial destabilization of
interphase microtubules. With respect to regulation of the dynamic
properties of MTs measured in vitro, Op18-tetraE closely resembles an
N-terminal truncation derivative of Op18. Thus, in a previous in vitro
study of MT assembly, analysis of Op18-
4-24-F revealed that the
catastrophe-promoting activity, but not the MT growth rate inhibitory
activity, requires the N-terminal region of Op18 (Howell et
al., 1999b
). To determine if the catastrophe-promoting activity of
overexpressed nonphosphorylatable Op18 was required for disruption of
the mitotic spindle, truncation derivatives of Op18 were substituted at
Ser-phosphorylation sites with Ala residues and expressed in K562
cells. One derivative, termed Op18-
4-24-tetraA-F, is
catastrophe-deficient while the other, termed
Op18-
100-147-tetraA-F, is catastrophe-proficient but lacks MT
growth rate inhibitory activity in vitro (Howell et al.,
1999b
). Analysis on a native gel confirmed that the expressed proteins
were nonphosphorylatable because the two truncated derivatives, as well
as the full-length Flag epitope-tagged version of Op18 (Op18-tetraA-F),
migrated as single bands (Figure 6A). The
transfection and expression conditions used resulted in comparable
expression levels of the two truncated proteins and Op18-tetraA-F
(Figure 6B).
|
The phenotypes of transfected cells were analyzed on the level of
MT polymerization status and cell cycle profiles. Analysis of
MT-polymerization status, which at the 6-h time-point primarily reflects activities in interphase cells, reveals somewhat decreased activities of both N- and C-terminally truncated Op18, but both derivatives still cause a rapid and dramatic MT-destabilization (Figure
6C). Most importantly, analysis of cell cycle profiles demonstrated a
clear-cut difference between the two nonphosphorylatable truncated
derivatives, as only the catastrophe-promoting
Op18-
100-147-tetraA-F derivative caused a mitotic block, followed
by mitotic slippage and endoreduplication (Figure 7). The apparent lack
of mitotic block in Op18-
4-24-tetraA-F expressing cells was not due
to a general cell cycle arrest or potential interference with a
metaphase checkpoint, because transfected cells readily accumulated in
mitosis in the presence of the MT-directed drug nocodazole (see insert in Figure 7). Moreover, dual analysis of Op18 expression and DNA content by flow cytometry showed that Op18-
4-24-tetraA-F, as well
as Op18-TetraE and the other derivatives employed in this study, was
evenly expressed throughout the cell cycle (data not shown). This
excludes mitosis specific degradation as the mechanism behind selective
disruption of interphase MTs.
|
To determine the severity of the phenotype of nonphosphorylatable
Op18-derivatives, spindle morphologies were manually inspected and
graded into three classes (normal and abnormal type I and II) described
and depicted in Figure 8. The percentage of normal versus abnormal
spindles was quantitated and normalized to the frequency of mitotic
cells, as defined by flow cytometry (Table 3). The data show that ectopic expression
of Op18-wt, Op18-
4-24-tetraA-F, and Op18-tetraE resulted in a small
increase in the fraction of mitotic cells, but the frequency of cells
with abnormal spindles was still low. In contrast, ectopic expression
of Op18-
100-147-tetraA-F results in a major increase in metaphase
cells. A large fraction of these cells contained type I abnormal
spindles, which is likely the cause of the mitotic block. Expression of
full-length Op18-tetraA resulted in the most extreme appearance of
mitotic cells, which to a large extent lacked detectable MT structures
(i.e., abnormal type II).
|
|
Taken together, the DNA profile reveals that Op18-
100-147-tetraA-F
retains potent metaphase checkpoint activating properties, but it is
still clear from morphological analysis that the C-terminal truncation
results in loss of a property that contributes to the severity of
mitotic spindle disruption. Nevertheless, it appears that the mitotic
spindle is primarily sensitive to the catastrophe-promoting activity of
Op18, because nonphosphorylatable catastrophe-deficient Op18-derivatives interfere minimally with formation of mitotic spindles. It follows that formation of the mitotic spindle is relatively resistant to other, as yet uncharacterized, activities of
Op18 that destabilizes interphase MTs.
| |
DISCUSSION |
|---|
|
|
|---|
Alteration at the N-Terminal Region Can Result in Selective Loss of Catastrophe-promoting Activity
Here, we describe the phenotypes of distinct types of Op18 mutants
in vitro and in intact cells during interphase and mitosis. Two of the
mutants analyzed, Op18-tetraE and Op18-
4-24, have alterations that
affect the N-terminal region of the protein. Both of these mutants
share a specific defect, namely an apparently selective loss of
catastrophe-promoting activity. The combined evidence from this and
previous studies shows that Glu-substitution and N-terminal deletion of
Op18 have similar phenotypic outcome. First, like Op18-wt, both types
of mutants bind two tubulins according to a two-site positive
cooperativity model, but with some decrease in binding affinity
(Larsson et al., 1999b
and Table 1). Second, neither
mutation has an effect on stimulation of soluble tubulin GTP hydrolysis
(Larsson et al., 1999b
and Figure 3). Third, both mutants
retain the ability to inhibit the tubulin polymerization rate, but they
have lost specific catastrophe-promoting activity in vitro (Howell
et al., 1999b
and Figure 4), and both are potent inhibitors
of taxol-driven in vitro polymerization of MTs (Larsson et
al., 1999a
and data not shown). Most interestingly, the present study in intact cells reveals that the interphase MT-destabilizing activity of both mutants is to a large extent retained, but these mutants do not interfere significantly with spindle formation.
The observed MT-destabilization by Op18-tetraE may appear to be in
conflict with two previous reports. In one report it was shown that Asp
substitutions at phosphorylation sites inhibited the MT-destabilizing
activity of Op18, as analyzed by microinjection of nocodazole
pretreated COS-7 cells (Horwitz et al., 1997
). In the other
report it was shown that Glu substitutions at phosphorylation sites
inhibited the MT-destabilizing activity of Op18 when transiently expressed in HeLa cells (Gavet et al., 1998
). However, in
these two studies, which relied on manual inspection of cells,
significant Op18 mediated decreases of the MT-network could only be
detected in a fraction of successfully microinjected/transfected cells (58.8% of Op18-wt injected COS-7 cells and ~ 37% of Op18-wt
expressing HeLa cells). The genetic system employed here is clearly
more sensitive as flow cytometric analysis reveals a dramatic (80-90% on average) destabilization of MTs in almost all cells within 6 h
of induced expression of Op18-wt (Larsson et al., 1999a
). Using this system, it is evident that Op18-tetraE has a significantly decreased MT-destabilizing activity as compared with Op18-wt, but flow
cytometric analysis still reveals a clear-cut activity of this
derivative in interphase cells (Figure 1), which was confirmed by
images of individual cells (Larsson et al., 1999a
). Hence, high and homogeneous expression levels, together with flow cytometric analysis of MT content, allow detailed comparison of partially inactivated Op18-derivatives.
Pseudophosphorylation by Glu-Substitutions Only Partially Mimics Activity-Attenuation by Authentic Phosphorylation
Nonphosphorylatable derivatives of Op18 are generated by
substitutions of phosphorylation sites with Ala residues with the assumption that the effects of Ser to Ala substitutions only reflect lack of phosphorylation of particular sites in intact cells. A mutant
with phosphorylation sites substituted with negatively charged Glu
residues are prepared with the assumption that these substitutions
provide at least a partial mimic of phosphorylation. The phenotype of
the Op18-tetraE mutant, as outlined above, is clearly different from
the effect of authentic phosphorylation. Combined results from previous
reports are in line with this conclusion. For example,
phosphorylations, but not Glu-substitutions, attenuate the inhibitory
activity of Op18 during taxol-driven MT polymerization (Larsson
et al., 1997
, 1999a
). In the present study, the effect of
Glu-substitutions of the four phosphorylation sites was compared with
the effect of phosphorylation on Ser-16 and Ser-63 of Op18. In both
cases, four negative charges are introduced into the N-terminal part of
Op18. Phosphorylation causes a somewhat more pronounced decrease in
Op18-tubulin binding affinity than Glu-substitution (~ 2-fold, Table
1), but similar to nonphosphorylated Op18 and Op18-tetraE,
phosphorylated Op18 bound two tubulins according to a two-site positive
cooperativity model. Because Op18-tetraE retains full tubulin GTPase
stimulatory activity, the twofold difference in binding affinity cannot
explain the virtual lack of GTPase stimulatory activity of
phosphorylated Op18. Moreover, it also seems unlikely that decreased
binding can explain that phosphorylation attenuates growth rate
inhibition during MT assembly at pH 6.8, since Op18-tetraE was in this
respect indistinguishable from nonphosphorylated Op18 (compare Figures
4 and 5).
The binding data presented in this study contrast with results from
chemical cross-linking assessment of the effect of Op18 phosphorylation
on tubulin binding-affinity (Larsson et al., 1997
; Gradin
et al., 1998
). Using chemical cross-linking it appeared that
dual phosphorylation on Ser-16 and Ser-63 had a major inhibitory impact
on tubulin binding, which was interpreted in favor of a mechanistic
model where phosphorylation-inactivation can be explained by loss of
tubulin complex formation (Lawler, 1998
; Andersen, 1999
). However, as
argued above, the current quantitative binding analyses and comparisons
of activity-profiles of Op18-tetraE and phosphorylated Op18 argues
strongly against such a simple model for phosphorylation-inactivation
of Op18.
Phosphorylation-inactivation of Op18 in intact cells has previously
been evaluated by a genetic system allowing conditional coexpression of
constitutively active cognate kinases and a series of kinase
target-site deficient mutants of Op18. The results show that
phosphorylation of Op18 on Ser-16 and Ser-63 is sufficient to switch
off virtually all Op18 activity in intact cells (Gradin et
al., 1998
). The approximate intracellular concentration of ectopic
Op18 in these experiments was around 50-100 µM, which exceeds the
estimated intracellular tubulin concentration (~ 20 µM) in K562
cells (Larsson et al., 1999b
). Given the binding data reported in the present study (Figure 3A and Table 1 and 2) and the
high intracellular Op18 and tubulin concentrations, which by far exceed
concentrations used for in vitro experiments, it is difficult to
envision that the modest phosphorylation-regulation of tubulin binding
affinity is sufficient to result in attenuation of Op18 activity in
transfected cells. This line of argumentation is supported by the
phenotype of Op18-tetraE, which differs only twofold in tubulin binding
affinity from phosphorylated Op18 but still efficiently destabilizes
interphase MTs (Figure 1). Hence, in agreement with in vitro
experiments, we conclude that phosphorylations, but not
Glu-substitutions, have the potential to attenuate both catastrophe-promotion and the poorly defined MT-destabilizing activity
associated with the C-terminal part of Op18, and furthermore, that this
attenuation cannot be accounted for by phosphorylation-regulation of
Op18-tubulin binding affinity in intact cells.
Differential Sensitivity of Interphase and Mitotic MTs to Distinct Activities of Op18
A recent study has shown that the catastrophe-promoting
Op18-
100-147-F derivative is severely affected in its
tubulin-binding affinity but still exerts a potent MT-destabilizing
activity in intact cells, which is independent of binding to tubulin
dimers (Larsson et al., 1999b
). Evidence for
catastrophe-promoting activity in intact cells was obtained by analysis
of MT density in the lamella region of microinjected newt lung cells,
as the observed lamella clearing indicated the expected shortening of
MTs indicative of a catastrophe factor (Larsson et al.,
1999b
). This suggests that at least the catastrophe-promoting activity
of Op18 is independent of interaction with free tubulin, and it follows
that the mechanism may involve interactions with MT ends. Here the cell
cycle phenotype of a nonphosphorylatable derivative,
Op18-
100-147-tetraA-F, was compared with two distinct
catastrophe-deficient and nonphosphorylatable derivatives of Op18,
namely Op18-tetraE and Op18-
4-24-tetraA-F. The data show that these
mutants have differential activities toward mitotic and interphase MTs,
which is in line with previous genetic evidence that Op18 mediates at
least two MT-directed activities in intact cells (Larsson et
al., 1999b
). Analysis of DNA-profiles suggested that the mitotic
spindle was completely resistant to destabilization by
catastrophe-deficient mutants, and examination of mitotic figures
revealed only a minor interference with the mitotic spindle (Table 3).
In contrast, catastrophe-proficient Op18-
100-147-tetraA-F blocked
essentially all cells in mitosis, and most cells showed visual defects
in their mitotic spindles. However, the defects were not as dramatic as
that caused by expression of the full-length Op18-tetraA-F derivative,
which resulted in the virtual absence of detectable spindle MTs. Thus,
the as yet undefined activities that require an intact C-terminus are
insufficient in themselves to block spindle formation, but these
activities can clearly cooperate with the catastrophe-promoting
activity of Op18 to obstruct the MT-system during mitosis.
How Does Op18 Decrease Interphase MT Content in the Absence of Catastrophe-Activity?
At present we can only speculate concerning the nature of the
activity that is absent in C-terminally truncated but present in
N-terminally truncated and Glu-substituted derivatives. Based on in
vitro assembly assays, this activity correlates with inhibition of
growth rate at pH 6.8, which was at that time interpreted to suggest a
tubulin sequestering-like activity (Howell et al., 1999b
and
Figure 4). If tubulin sequestering is involved in the mechanism by
which Op18-tetraE and Op18-
4-24-tetraA-F selectively destabilize interphase MTs, it follows that mitotic MTs would be insensitive to
such a tubulin sequestering mechanism. This seems unlikely and, as
argued above and in a previous report (Larsson et al., 1999b
), a potential sequestering activity of Op18 appears to play a
minor role in intact cells. For example, the concentration of endogenous Op18 (~ 10 µM) in K562 leukemia cells is sufficient to
form ternary complexes with essentially all cellular tubulin (~ 20 µM) (Larsson et al., 1999b
). By analyzing Op18-tubulin
interactions in crude extracts of transfected K562 cells, we have
previously shown that ectopic N-terminally truncated Op18 shows
very low levels of association with endogenous tubulin. This could be
explained by decreased tubulin binding-affinity of truncated Op18, as
this results in endogenous Op18 out-competing binding in a crude
extract (Larsson et al., 1999b
). Hence, it seems unlikely
that tubulin sequestering is responsible for the as yet undefined
MT-destabilizing activity of Op18-
4-24-F.
In summary, the present study shows that catastrophe-promotion by Op18
is sufficient to disrupt the mitotic spindle, while the activity that
requires an intact C-terminus of Op18 destabilizes primarily the
interphase network of MTs. This suggests functional differences between
interphase and mitotic MTs, which may be the result of differential
binding of MAPs during these two cell cycle stages (reviewed by
Cassimeris, 1999
). Our results confirm that Op18 exerts at least two
distinct activities in intact cells, and an important goal will be to
elucidate the nature of the activity associated with the C-terminal
region of Op18. If this can be achieved, the
nonphosphorylatable/constitutively active Op18 mutants characterized in
this report will become even more interesting tools to dissect
functional differences between the MT-system during interphase and mitosis.
| |
ACKNOWLEDGMENTS |
|---|
We thank V. Shingler for helpful discussions and K. Fridell for assistance with in vitro phosphorylations. P.H., N.L., B.S., and M.G. were supported by Swedish Natural Science Research Council and the Swedish Society for Medical Research. B.H., L.C., and J.M. were supported by a grant from the National Institutes of Health.
| |
FOOTNOTES |
|---|
Present address: Dept. of Biology, University of
North Carolina, Chapel Hill, NC 27599.
§ These authors contributed equally to this work and are listed in alphabetical order
¶ Corresponding author. E-mail address: Martin.Gullberg{at}cmb.umu.se.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
AMP-PNP, adenyl-5'-yl imidodiphosphate;
MT, microtubule;
MAP, microtubule-associated protein;
Op18, Oncoprotein
18/stathmin;
Op18-F, FLAG epitope-tagged Op18;
SDS-PAGE, sodium dodecyl
sulfate-polyacrylamide gel electrophoresis;
Op18-
4-24-tetraA-F, nonphosphorylatable Op18-F with amino acids 4-24 deleted and
substituted at Ser- 3, 25, 38 and 63 with Ala;
Op18-
100-147-tetraA-F, nonphosphorylatable Op18-F with amino acids
100-147 deleted and substituted at Ser-16, 25, 38 and 63 with Ala;
Op18-tetraA, nonphosphorylatable full-length Op18 substituted at
Ser-16, 25, 38 and 63 with Ala;
Op18-tetraE, nonphosphorylatable
full-length Op18 substituted at Ser-16, 25, 38 and 63 with Glu.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. E. Sellin, P. Holmfeldt, S. Stenmark, and M. Gullberg Global Regulation of the Interphase Microtubule System by Abundantly Expressed Op18/Stathmin Mol. Biol. Cell, July 1, 2008; 19(7): 2897 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Belletti, M. S. Nicoloso, M. Schiappacassi, S. Berton, F. Lovat, K. Wolf, V. Canzonieri, S. D'Andrea, A. Zucchetto, P. Friedl, et al. Stathmin Activity Influences Sarcoma Cell Shape, Motility, and Metastatic Potential Mol. Biol. Cell, May 1, 2008; 19(5): 2003 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holmfeldt, K. Brannstrom, S. Stenmark, and M. Gullberg Aneugenic Activity of Op18/Stathmin Is Potentiated by the Somatic Q18->E Mutation in Leukemic Cells Mol. Biol. Cell, July 1, 2006; 17(7): 2921 - 2930. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zahedi, M. P. Revelo, S. Barone, Z. Wang, K. Tehrani, D. P. Citron, J. J. Bissler, H. Rabb, and M. Soleimani Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury Am J Physiol Renal Physiol, June 1, 2006; 290(6): F1559 - F1567. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Manna, D. Thrower, H. P. Miller, P. Curmi, and L. Wilson Stathmin Strongly Increases the Minus End Catastrophe Frequency and Induces Rapid Treadmilling of Bovine Brain Microtubules at Steady State in Vitro J. Biol. Chem., January 27, 2006; 281(4): 2071 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Giampietro, F. Luzzati, G. Gambarotta, P. Giacobini, E. Boda, A. Fasolo, and I. Perroteau Stathmin Expression Modulates Migratory Properties of GN-11 Neurons in Vitro Endocrinology, April 1, 2005; 146(4): 1825 - 1834. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zahedi, Z. Wang, S. Barone, K. Tehrani, N. Yokota, S. Petrovic, H. Rabb, and M. Soleimani Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure Am J Physiol Cell Physiol, May 1, 2004; 286(5): C1203 - C1211. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wittmann, G. M. Bokoch, and C. M. Waterman-Storer Regulation of Microtubule Destabilizing Activity of Op18/Stathmin Downstream of Rac1 J. Biol. Chem., February 13, 2004; 279(7): 6196 - 6203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Honnappa, B. Cutting, W. Jahnke, J. Seelig, and M. O. Steinmetz Thermodynamics of the Op18/Stathmin-Tubulin Interaction J. Biol. Chem., October 3, 2003; 278(40): 38926 - 38934. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holmfeldt, G. Brattsand, and M. Gullberg Interphase and monoastral-mitotic phenotypes of overexpressed MAP4 are modulated by free tubulin concentrations J. Cell Sci., September 15, 2003; 116(18): 3701 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Holmfeldt, K. Brannstrom, S. Stenmark, and M. Gullberg Deciphering the Cellular Functions of the Op18/Stathmin Family of Microtubule-Regulators by Plasma Membrane-targeted Localization Mol. Biol. Cell, September 1, 2003; 14(9): 3716 - 3729. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brannstrom, B. Segerman, and M. Gullberg Molecular Dissection of GTP Exchange and Hydrolysis within the Ternary Complex of Tubulin Heterodimers and Op18/Stathmin Family Members J. Biol. Chem., May 2, 2003; 278(19): 16651 - 16657. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tamura, T. Hara, M. Yoshie, S. Irie, A. Sobel, and H. Kogo Enhanced Expression of Uterine Stathmin during the Process of Implantation and Decidualization in Rats Endocrinology, April 1, 2003; 144(4): 1464 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Segerman, P. Holmfeldt, J. Morabito, L. Cassimeris, and M. Gullberg Autonomous and phosphorylation-responsive microtubule-regulating activities of the N-terminus of Op18/stathmin J. Cell Sci., January 1, 2003; 116(1): 197 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Alli, J. Bash-Babula, J.-M. Yang, and W. N. Hait Effect of Stathmin on the Sensitivity to Antimicrotubule Drugs in Human Breast Cancer Cancer Res., December 1, 2002; 62(23): 6864 - 6869. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Amayed, D. Pantaloni, and M.-F. Carlier The Effect of Stathmin Phosphorylation on Microtubule Assembly Depends on Tubulin Critical Concentration J. Biol. Chem., June 14, 2002; 277(25): 22718 - 22724. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuntziger, O. Gavet, A. Sobel, and M. Bornens Differential Effect of Two Stathmin/Op18 Phosphorylation Mutants on Xenopus Embryo Development J. Biol. Chem., June 15, 2001; 276(25): 22979 - 22984. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||